-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, QpT4+3CiPNjbi2v9KpTg9JPmB635Wb3y5MP30JKkLtt3D7SwDP5ScFHT9/Pl+BWd 8/tk3aXI7ofTC33KjZkTdg== 0000930413-07-008132.txt : 20071024 0000930413-07-008132.hdr.sgml : 20071024 20071024170032 ACCESSION NUMBER: 0000930413-07-008132 CONFORMED SUBMISSION TYPE: SC 13D/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20071024 DATE AS OF CHANGE: 20071024 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: MEMORY PHARMACEUTICALS CORP CENTRAL INDEX KEY: 0001062216 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 FILING VALUES: FORM TYPE: SC 13D/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-80464 FILM NUMBER: 071188643 BUSINESS ADDRESS: STREET 1: 100 PHILIPS PARKWAY CITY: MONTVALE STATE: NJ ZIP: 07645 BUSINESS PHONE: 2018027100 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: GREAT POINT PARTNERS LLC CENTRAL INDEX KEY: 0001281446 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A MAIL ADDRESS: STREET 1: 2 PICKWICK PLAZA STREET 2: STE 450 CITY: GREENWICH STATE: CT ZIP: 06830 SC 13D/A 1 c50894_sc13da.txt --------------------------------- OMB APPROVAL OMB Number: 3235-0145 Expires: February 28, 2009 Estimated average burden hours per response..... 14.5 --------------------------------- UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13D UNDER THE SECURITIES EXCHANGE ACT OF 1934 (AMENDMENT NO. 4)* MEMORY PHARMACEUTICALS CORP. - -------------------------------------------------------------------------------- (Name of Issuer) COMMON STOCK, PAR VALUE $.001 PER SHARE - -------------------------------------------------------------------------------- (Title of Class of Securities) 58606R403 - -------------------------------------------------------------------------------- (CUSIP Number) DAVID GERBER GREAT POINT PARTNERS, LLC 165 MASON STREET, 3RD FLOOR GREENWICH, CT 06830. (203) 971-3300 - -------------------------------------------------------------------------------- (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) OCTOBER 22, 2007 - -------------------------------------------------------------------------------- (Date of Event which Requires Filing of this Statement) If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of ss.ss.240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. |_| NOTE: Schedule filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See ss.240.13d-7 for other parties to whom copies are to be sent. *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). PERSONS WHO RESPOND TO THE COLLECTION OF INFORMATION CONTAINED IN THIS FORM ARE NOT REQUIRED TO RESPOND UNLESS THE FORM DISPLAYS A CURRENTLY VALID OMB CONTROL NUMBER. - ------------------------- CUSIP No. 58606R403 - ------------------------- ================================================================================ 1 Names of Reporting Persons. Great Point Partners, LLC I.R.S. Identification Nos. of above persons (entities only). 37-1475292 - -------------------------------------------------------------------------------- 2 Check the Appropriate Box if a Member of a Group (See Instructions) (a) |_| (b) |_| - -------------------------------------------------------------------------------- 3 SEC Use Only - -------------------------------------------------------------------------------- 4 Source of Funds (See Instructions) AF - -------------------------------------------------------------------------------- 5 Check if Disclosure of Legal Proceedings is Required Pursuant to Items 2(d) or 2(e) |_| - -------------------------------------------------------------------------------- 6 Citizenship or Place of Organization Delaware - -------------------------------------------------------------------------------- Number of Shares 7 Sole Voting Power -0- --------------------------------------------- Beneficially Owned by 8 Shared Voting Power 10,225,000 --------------------------------------------- Each Reporting Person With 9 Sole Dispositive Power -0- --------------------------------------------- 10 Shared Dispositive Power 10,225,000 - -------------------------------------------------------------------------------- 11 Aggregate Amount Beneficially Owned by Each Reporting Person 10,225,000 - -------------------------------------------------------------------------------- 12 Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions) - -------------------------------------------------------------------------------- 13 Percent of Class Represented by Amount in Row (11) 14.08% - -------------------------------------------------------------------------------- 14 Type of Reporting Person (See Instructions) OO --------------------------------------------------------------------- --------------------------------------------------------------------- --------------------------------------------------------------------- ================================================================================ 2 - ------------------------- CUSIP No. 58606R403 - ------------------------- ================================================================================ 1 Names of Reporting Persons. Dr. Jeffrey R. Jay, M.D. I.R.S. Identification Nos. of above persons (entities only). - -------------------------------------------------------------------------------- 2 Check the Appropriate Box if a Member of a Group (See Instructions) (a) |_| (b) |_| - -------------------------------------------------------------------------------- 3 SEC Use Only - -------------------------------------------------------------------------------- 4 Source of Funds (See Instructions) AF - -------------------------------------------------------------------------------- 5 Check if Disclosure of Legal Proceedings is Required Pursuant to Items 2(d) or 2(e) |_| - -------------------------------------------------------------------------------- 6 Citizenship or Place of Organization United States - -------------------------------------------------------------------------------- Number of Shares 7 Sole Voting Power -0- --------------------------------------------- Beneficially Owned by 8 Shared Voting Power 10,225,000 --------------------------------------------- Each Reporting Person With 9 Sole Dispositive Power -0- --------------------------------------------- 10 Shared Dispositive Power 10,225,000 - -------------------------------------------------------------------------------- 11 Aggregate Amount Beneficially Owned by Each Reporting Person 10,225,000 - -------------------------------------------------------------------------------- 12 Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions) - -------------------------------------------------------------------------------- 13 Percent of Class Represented by Amount in Row (11) 14.08% - -------------------------------------------------------------------------------- 14 Type of Reporting Person (See Instructions) IN --------------------------------------------------------------------- --------------------------------------------------------------------- --------------------------------------------------------------------- ================================================================================ 3 - ------------------------- CUSIP No. 58606R403 - ------------------------- ================================================================================ 1 Names of Reporting Persons. Biomedical Value Fund, L.P. I.R.S. Identification Nos. of above persons (entities only). 37-1475295 - -------------------------------------------------------------------------------- 2 Check the Appropriate Box if a Member of a Group (See Instructions) (a) |_| (b) |_| - -------------------------------------------------------------------------------- 3 SEC Use Only - -------------------------------------------------------------------------------- 4 Source of Funds (See Instructions) PF - -------------------------------------------------------------------------------- 5 Check if Disclosure of Legal Proceedings is Required Pursuant to Items 2(d) or 2(e) |_| - -------------------------------------------------------------------------------- 6 Citizenship or Place of Organization Delaware - -------------------------------------------------------------------------------- Number of Shares 7 Sole Voting Power -0- --------------------------------------------- Beneficially Owned by 8 Shared Voting Power 5,521,499 --------------------------------------------- Each Reporting Person With 9 Sole Dispositive Power -0- --------------------------------------------- 10 Shared Dispositive Power 5,521,499 - -------------------------------------------------------------------------------- 11 Aggregate Amount Beneficially Owned by Each Reporting Person 5,521,499 - -------------------------------------------------------------------------------- 12 Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions) - -------------------------------------------------------------------------------- 13 Percent of Class Represented by Amount in Row (11) 7.61% - -------------------------------------------------------------------------------- 14 Type of Reporting Person (See Instructions) PN --------------------------------------------------------------------- --------------------------------------------------------------------- --------------------------------------------------------------------- ================================================================================ 4 - ------------------------- CUSIP No. 58606R403 - ------------------------- ================================================================================ 1 Names of Reporting Persons. Biomedical Offshore Value Fund, Ltd. I.R.S. Identification Nos. of above persons (entities only). N/A - -------------------------------------------------------------------------------- 2 Check the Appropriate Box if a Member of a Group (See Instructions) (a) |_| (b) |_| - -------------------------------------------------------------------------------- 3 SEC Use Only - -------------------------------------------------------------------------------- 4 Source of Funds (See Instructions) PF - -------------------------------------------------------------------------------- 5 Check if Disclosure of Legal Proceedings is Required Pursuant to Items 2(d) or 2(e) |_| - -------------------------------------------------------------------------------- 6 Citizenship or Place of Organization Cayman Islands - -------------------------------------------------------------------------------- Number of Shares 7 Sole Voting Power -0- --------------------------------------------- Beneficially Owned by 8 Shared Voting Power 4,703,501 --------------------------------------------- Each Reporting Person With 9 Sole Dispositive Power -0- --------------------------------------------- 10 Shared Dispositive Power 4,703,501 - -------------------------------------------------------------------------------- 11 Aggregate Amount Beneficially Owned by Each Reporting Person 4,703,501 - -------------------------------------------------------------------------------- 12 Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions) - -------------------------------------------------------------------------------- 13 Percent of Class Represented by Amount in Row (11) 6.48% - -------------------------------------------------------------------------------- 14 Type of Reporting Person (See Instructions) OO --------------------------------------------------------------------- --------------------------------------------------------------------- --------------------------------------------------------------------- ================================================================================ 5 This Amendment No. 4 to Schedule 13D (this "Amendment") is filed by the undersigned to amend the Statement on Schedule 13D, filed by the undersigned on October 24, 2006, as amended by Amendment No. 1, filed by the undersigned on October 17, 2007, as amended by Amendment No. 2, filed by the undersigned on October 17, 2007, as amended by Amendment No. 3, filed by the undersigned on October 22, 2007 (collectively, the "Original Filing"). Unless otherwise indicated, all capitalized terms shall have the same meaning as provided in the Original Filing. Any reference to "this Schedule 13D" in the Original Filing or in this Amendment shall refer to the Original Filing as amended by this Amendment. ITEM 5. INTEREST IN SECURITIES OF THE ISSUER Item 5 is hereby amended and restated as follows: (a) through (b) BMVF owns in the aggregate 5,521,499 shares of Common Stock of the issuer. Such shares in the aggregate constitute 7.61% of the shares of Common Stock outstanding, computed in accordance with Rule 13d-3. BMVF shares voting and dispositive power over the shares of Common Stock that it beneficially owns. BOVF owns in the aggregate 4,703,501shares of Common Stock of the issuer. Such shares in the aggregate constitute 6.48% of the shares of Common Stock outstanding, computed in accordance with Rule 13d-3. BOVF shares voting and dispositive power over the shares of Common Stock that it beneficially owns. Great Point is the investment manager of each of BMVF and BOVF and by virtue of such status may be deemed to be the beneficial owner of the shares of Common Stock held by BMVF and BOVF. Dr. Jay, as senior managing member of Great Point, has shared voting and investment power with respect to the shares of Common Stock held by BMVF and BOVF and may be deemed to be the beneficial owner of such shares. Great Point and Dr. Jay disclaim beneficial ownership of the shares of Common Stock held by BMVF and BOVF, except to the extent of any pecuniary interest, and this statement shall not be deemed to be an admission that they are the beneficial owners of such securities. (c) From the period between October 15, 2007 and October 23, 2007 BMVF sold 1,912,397 shares of Common Stock of the issuer held by it and BOVF sold 1,629,078 shares of Common Stock of the issuer held by it. (d) Not applicable. (e) Not applicable. ITEM 6. CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS OR RELATIONSHIPS WITH RESPECT TO SECURITIES OF THE ISSUER Not applicable. 6 ITEM 7. MATERIALS TO BE FILED AS EXHIBITS EXHIBIT A: Joint Filing Agreement, dated as of October 24, 2007. 7 SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Date: October 24, 2007 Biomedical Value Fund, L.P. By: Great Point GP, LLC, its general partner By: /s/ DR. JEFFREY R. JAY ----------------------------------------- Name: Dr. Jeffrey R. Jay Title: Senior Managing Member Biomedical Offshore Value Fund, Ltd. By: Great Point GP, LLC, its investment manager By: /s/ DR. JEFFREY R. JAY ----------------------------------------- Name: Dr. Jeffrey R. Jay Title: Senior Managing Member Great Point Partners, LLC By: /s/ DR. JEFFREY R. JAY ----------------------------------------- Name: Dr. Jeffrey R. Jay Title: Senior Managing Member /s/ DR. JEFFREY R. JAY -------------------------------------------- Dr. Jeffrey R. Jay, individually 8 AGREEMENT REGARDING THE JOINT FILING OF SCHEDULE 13D The undersigned hereby agree as follows: (i) Each of them is individually eligible to use the Schedule 13D to which this Exhibit is attached, and such Schedule 13D is filed on behalf of each of them; and (ii) Each of them is responsible for the timely filing of such Schedule 13D and any amendments thereto, and for the completeness and accuracy of the information concerning such person contained therein; but none of them is responsible for the completeness or accuracy of the information concerning the other persons making the filing, unless such person knows or has reason to believe that such information is inaccurate. Date: October 24, 2007 Biomedical Value Fund, L.P. By: Great Point GP, LLC, its general partner By: /s/ DR. JEFFREY R. JAY ----------------------------------------- Name: Dr. Jeffrey R. Jay Title: Senior Managing Member Biomedical Offshore Value Fund, Ltd. By: Great Point GP, LLC, its investment manager By: /s/ DR. JEFFREY R. JAY ----------------------------------------- Name: Dr. Jeffrey R. Jay Title: Senior Managing Member Great Point Partners, LLC By: /s/ DR. JEFFREY R. JAY ----------------------------------------- Name: Dr. Jeffrey R. Jay Title: Senior Managing Member /s/ DR. JEFFREY R. JAY ----------------------------------------- Dr. Jeffrey R. Jay, individually 9 -----END PRIVACY-ENHANCED MESSAGE-----